title: Reply to: Comment on: 'Long-term impact of liver function on curative therapy for hepatocellular carcinoma: application of the ALBI grade'.
authors.affiliation: Department of Molecular and Clinical Cancer Medicine, The Duncan Building, Daulby Street, University of Liverpool, Liverpool L69 3GA, UK.|The Clatterbridge Cancer Centre NHS Foundation Trust, Clatterbridge Road, Bebington, Wirral CH63 4JY, UK.
authors.forename: Philip
authors.initials: P
authors.lastname: Johnson
authors.affiliation: Department of Surgery, Prince of Wales Hospital, Chinese University of Hong Kong, Hong Kong, China.
authors.forename: Paul Bs
authors.initials: PB
authors.lastname: Lai
authors.affiliation: Department of Gastroenterology and Hepatology, Ogaki Municipal Hospital, 4-86 Minaminokawa-cho, Ogaki, Gifu 503-8052, Japan.
authors.forename: Hidenori
authors.initials: H
authors.lastname: Toyoda
mesh_terms: D001663:Bilirubin; D006528:Carcinoma, Hepatocellular; D006801:Humans; D008111:Liver Function Tests; D008113:Liver Neoplasms
chemical_list: D001663:Bilirubin